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High-throughput X-ray crystal structures of protein–ligand complexes are
critical to pharmaceutical drug development. However, cryocooling of crystals
and X-ray radiation damage may distort the observed ligand binding. Serial
femtosecond crystallography (SFX) using X-ray free-electron lasers (XFELs)
can produce radiation-damage-free room-temperature structures. Ligand-binding
studies using SFX have received only modest attention, partly owing to limited
beamtime availability and the large quantity of sample that is required per
structure determination. Here, a high-throughput approach to determine room-
temperature damage-free structures with excellent sample and time efficiency is
demonstrated, allowing complexes to be characterized rapidly and without
prohibitive sample requirements. This yields high-quality difference density
maps allowing unambiguous ligand placement. Crucially, it is demonstrated that
ligands similar in size or smaller than those used in fragment-based drug design
may be clearly identified in data sets obtained from <1000 diffraction images.
This efficiency in both sample and XFEL beamtime opens the door to true high-
throughput screening of protein–ligand complexes using SFX.
1. Introduction
The accurate determination of the structures of protein–ligand
complexes is essential for drug discovery, enzymology and
biotechnology. Developments in the automation of protein
crystallization, ligand soaking, harvesting, structure determi-
nation, ligand modelling and structural refinement have
allowed the high-throughput screening of soaked crystals at
synchrotron X-ray beamlines (Collins et al., 2018; Pearce,
Krojer, Bradley et al., 2017; Pearce, Krojer & von Delft, 2017).
For important classes of proteins, the binding of ligands may
be affected by X-ray-driven changes either in the oxidation
state of redox centres within the protein or to amino-acid side
chains involved in protein–ligand interactions. In these cases,
there is a premium on structure determination using low-dose
methods. Prime examples of this are heme enzymes, where the
iron centre in resting iron(III) and high-valent iron(IV) states
is exquisitely prone to reduction by solvated photoelectrons
generated by the interaction of synchrotron X-rays with
solvent in the crystal (see, for example, Beitlich et al., 2007;
Kekilli et al., 2017). Heme enzymes, such as the cytochrome
P450s, are involved in the metabolism/breakdown of
approximately 90% of small-molecule drugs, and are more
generally themselves drug targets in yeast, fungi and tuber-
culosis infections (McLean & Munro, 2017; Guengerich et al.,
2016; Rendic & Guengerich, 2015). Importantly, the deter-
mination of protein–ligand complexes at room temperature is
likely to better reflect in vivo conditions than crystals cryo-
genically cooled to 100 K (for an interesting example, see
Fischer et al., 2015). Indeed, significant differences in binding
have been observed at room temperature (RT) compared with
100 K (Keedy et al., 2018). Furthermore, ligand soaking into
microcrystals (1–20 mm) has the theoretical potential to be
more effective than soaking into larger crystals (>50 mm)
(McPherson, 2019). The distance that a ligand needs to
penetrate into the crystal to reach its centre is proportionately
shorter for smaller crystals, potentially leading to higher
occupancy rates.
These issues in combination place a high value on protein–
ligand complexes determined from microcrystals at RT that
are free of observable effects of radiation damage. The only
current approach that can deliver this is serial femtosecond
crystallography (SFX) at X-ray free-electron lasers (XFELs;
Schlichting, 2015) using short (<20 fs) X-ray pulses (Inoue et
al., 2016; Lomb et al., 2011; Nass et al., 2015; Nass, 2019).
Ligand-binding studies using SFX have received little atten-
tion, largely owing to the scarcity of beamtime and high
sample requirements in typical sample-delivery systems such
as the gas dynamic virtual nozzle (GDVN) injectors
(Schlichting, 2015). The drive to obtain damage-free, RT
structures is balanced against the strong practical driver to
minimize sample consumption per obtained structure, and the
desire to collect data from multiple candidate ligands in a
short time period.
A limited number of studies have sought to address the
challenge of obtaining damage-free, RT crystal structures of
protein–ligand complexes in a manner that is efficient both in
sample and in data-collection time. An early study examined
ligand binding to a P-type ATPase membrane protein in
microcrystals delivered to the beam using a liquid microjet
injector (Bublitz et al., 2015). This work demonstrated the
applicability of SFX to ligand-binding studies, showing that
ligands could be clearly resolved even if the high-resolution
data collected are weak and statistically poor. A more recent
study (Naitow et al., 2017) explored the feasibility of SFX
ligand-binding studies using microcrystals of the model system
thermolysin delivered by a high-viscosity water- or oil-based
injector. The small-molecule ligand was readily resolved in
electron-density maps, with clear differences in binding modes
observed between the room-temperature SFX and 100 K
synchrotron-radiation (SR) structures.
Here, we describe the rapid determination of protein–
ligand complexes at RT. Microcrystals were mounted in silicon
fixed targets or ‘chips’ at the SPring-8 A˚ngstrom Free Electron
Laser (SACLA), Hyogo, Japan (Ishikawa et al., 2012). The
fixed-target sample-delivery approach minimizes sample
consumption, provides high hit rates and allows multiple high-
quality data sets to be measured in a very short time, an
important advantage given the limited availability of XFEL
beamtime. The chip system also allows rapid switching
experiments in which crystals of different targets are soaked
with different ligands. Moreover, the short time between
soaking, chip loading and the completion of data collection
reduces the need for long-term protein–ligand crystal stability
that is required for a typical injector experiment. This also
ensures that crystals are exposed to the soaked ligand for a
similar length of time.
We have applied this approach to crystals of two heme
peroxidase enzymes: a multifunctional dehaloperoxidase from
the marine annelid Amphitrite ornata (DHP-B; Barrios et al.,
2014; Franzen et al., 2012; McCombs, Moreno-Chicano, et al.,
2017; McCombs, Smirnova et al., 2017) and a dye-decolour-
izing peroxidase (Sugano, 2009) of industrial relevance (Colpa
et al., 2014) from Streptomyces lividans (DtpAa). We also
examine the challenging case of detecting nitrite binding to
copper nitrite reductase from Achromobacter cycloclastes
(AcNiR; Horrell et al., 2017), where the ligand displaces a
water molecule bound in the active site. The enzyme and
crystal systems used are of cubic (high), orthorhombic
(medium) and monoclinic (low) symmetry space groups, as
well as exhibiting full to partial ligand occupancies within the
same crystallographic asymmetric units. The complexes
investigated include ligands directly binding to the heme,
together with those occupying a binding pocket but not bound
to the iron, with ligand sizes of 3–10 non-H atoms (Supple-
mentary Fig. S1). We note that the typical molecular weight of
the fragments used in fragment-based drug design is
approximately 150–250 Da, with a typical size of 200 Da (Price
et al., 2017).
We explore the potential of this approach for rapid SFX
screening of ligands/drug candidates, examining the minimum
number of merged diffraction patterns required to reliably
detect ligand binding and the future potential of this approach
at current and planned XFEL beamlines. We assess several
metrics for ligand fit to electron density with the data sets
presented in the light of the recent debate around ligand
validation (Smart et al., 2018). Remarkably, data sets
comprising of <1000 merged diffraction patterns allowed clear
and unambiguous identification of ligand-binding modes,
despite extremely poor merging and refinement statistics. The
number of crystals required for complete data is lowered by
the bandwidth of the XFEL beam. Our work thus demon-
strates that high-throughput screening is eminently practicable
using SFX, with modest requirements for sample quantity and
experimental time.
2. Materials and methods
2.1. Protein production and crystallization
Dye-type peroxidase Aa (DtpAa) from S. lividans was
expressed and purified as described previously (Ebrahim,
Moreno-Chicano et al., 2019). Crystals were grown in batch
using a modification of the crystallization conditions used for
growing large single crystals, consisting of 25%(w/v) PEG
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1500 and 100 mM MIB buffer (Hampton Research, comprising
MES, boric acid and imidazole pH 8). The final protein
concentration in the batches ranged from 6.5 to 2.1 mg ml1.
Crystals grew in 1–2 days to approximate dimensions of 20–
30 mm and were transported to SACLA at ambient tempera-
ture (the crystals were transported in hand luggage without
cooling). Dehaloperoxidase B (DHP) from A. ornata was
expressed and purified as described previously (McCombs,
Moreno-Chicano et al., 2017). Batch microcrystallization was
used, mixing 30 mg ml1 DHP in 20 mM MES pH 6.0 with
40%(w/v) PEG 4000, 200 mM ammonium sulfate in a 1:4 ratio
in a total volume of 250–500 ml. DHP microcrystals grew in 3–
5 days at 4C to typical dimensions of 20–30 mm and were
transported to SACLA at 4C. 5-Bromoindole (5BR) and 2,4-
dichlorophenol (DCP) (Sigma) were each dissolved in 100%
DMSO and 20 ml of the resulting solution was added to a
200 ml crystal suspension to yield final ligand concentrations of
5 mM DCP and 50 mM 5BR. Microcrystals were soaked in
batches for 3–5 min immediately prior to loading onto the
silicon chip. AcNiR microcrystals were grown as described
previously (Ebrahim, Appleby et al., 2019) and were soaked in
100 mM potassium nitrite for approximately 20 min prior to
loading onto the chip.
2.2. Data collection and processing
Microcrystals were loaded into fixed-target chips as
described previously (Ebrahim, Appleby et al., 2019; Oghbaey
et al., 2016). The chips were fabricated commercially (South-
ampton Nanofabrication Centre; https://www.southampton-
nanofab.com) using a method based on that described
previously (Oghbaey et al., 2016). Typically, 100–200 ml of
microcrystal suspension was loaded onto a chip containing
25 600 apertures and excess liquid was removed using a weak
vacuum applied to the underside of the chip surface. For DHP
microcrystals around 1.5 mg of protein was loaded in each
chip, requiring around 4.5 mg for a complete data set (three or
four chips), while AcNiR microcrystals were loaded in quan-
tities of around 2 mg for a complete data set (two chips at 1 mg
per chip). In the case of DtpAa even less protein was needed:
only 0.45–6.0 mg per chip and around 1.80 mg for a complete
data set. SFX data were measured on SACLA (Ishikawa et al.,
2012) beamline BL2 EH3 with a photon energy of 10.0 keV, a
repeat rate of 30 Hz and a pulse length of 10 fs. The beam,
with a 1.25  1.34 mm spot size (FWHM) and a pulse energy of
289 mJ per pulse (pre-attenuation), was attenuated to 13% of
full flux to minimize detector overloads. The SACLA beam
was in SASE mode, with FWHM bandwidth 70 eV. The
fixed-target chip was translated between X-ray pulses such
that each crystal position was exposed only once, and the
measurement of all 25 600 positions on a chip took 14 min.
The hit rate during data collection was monitored using
Cheetah (Barty et al., 2014), while peak finding, indexing and
merging of data were performed using CrystFEL v.0.6.4
(White et al., 2016). Structures were refined using starting
models of ligand-free structures from which water and other
solvent molecules had been removed. Refinement was initially
carried out in REFMAC5 (Murshudov et al., 2011) within the
CCP4 suite and completed in PHENIX (Adams et al., 2010).
All structures were validated using MolProbity (Williams et
al., 2018), the JCSG Quality Control Check server and tools
within PHENIX (Adams et al., 2010) and Coot (Emsley et al.,
2010).
To explore the limits of ligand identification in SFX data
sets, randomly selected images from the indexed data
(*.stream files from CrystFEL) formed data subsets with
defined, variable numbers of images. These were scaled and
merged in the same manner as the data sets containing all
images and were used in refinement versus the model for the
appropriate complex determined using all data, from which
the ligand had been removed. OMIT maps were generated
using torsion-based simulated-annealing refinement in
phenix.refine (Adams et al., 2010) in order to minimize model
bias. As an additional validation step, selected subsets were
refined against the structure of the native enzymes (where the
ligands were not present) using the procedure described
above.
2.3. Ligand modelling
Ligands were initially modelled into the all-image data sets
based on the mFo  DFc difference electron-density maps. In
all cases, ligand density was unambiguous and ligands were
modelled with near-full occupancy in one of the two subunits
of the homodimeric enzymes (for DHP and DtpAa) or in the
single subunit of AcNiR in the crystallographic asymmetric
unit. The ligands were straightforwardly located in an auto-
mated manner using the ‘Find Ligands’ feature of Coot. The
second monomer in the DHP asymmetric unit contained a
lower occupancy ligand (5BR) or very weak ligand density
(DCP), while in DtpAa the second monomer did not show a
bound exogenous ligand in the active site. Restraints for
nonstandard ligands were produced using ACEDRG (Long et
al., 2017). For the data subsets, the data were refined by two
parallel approaches to avoid model bias. Firstly, the data were
refined against the ‘all-images’ structures, from which the
ligands had been removed, using simulated annealing in
phenix.refine to remove bias. As an additional test that bias
was not present, selected structures were refined against the
native, ligand-free structures of the enzymes and simulated-
annealing (SA) OMIT difference maps were generated. The
known position of the ligand from the ‘all-images’ models was
then compared with the difference density map generated
from that subset. The quality of the fit of modelled ligands to
the electron-density maps was determined using EDIAscorer
(Meyder et al., 2017). The ‘Find Ligands’ feature of Coot was
also used for each subset, in this case searching the mFo DFc
SA OMIT map for suitable hits.
Fo  Fo isomorphous difference maps between the DHP–
5BR and DHP–DCP data sets were generated in PHENIX
with the native ligand-free DHP structure (see below) used to
phase the data sets (although near-identical results were
generated if either of the above ligand-bound structures were
used for phasing).
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3. Results
3.1. Determination of protein–ligand complex structures by
SFX in a time- and sample-efficient manner
SFX structures for each enzyme–ligand complex were
determined from data measured from either two (AcNiR),
three (DHP–DCP) or four (DHP–5BR and DtpAa–imida-
zole) chips. This took approximately 14 min of data collection
and 16 min of beamtime per chip (sample-change, hutch-
search and alignment time are included). In each case, struc-
ture solution was by molecular replacement and the resolution
and data quality were sufficient to clearly define essentially all
main-chain and most side-chain atoms together with well
defined networks of water molecules. The quality of the data
sets and structures is given in Table 1. For each structure, clear
positive difference density was evident for the ligands, which
were unambiguously located. The chemical structures of the
ligands used in this study are shown in Supplementary Fig. S1.
3.2. SFX structures of ligand-bound complexes
In each DHP structure, clear Fo  Fc electron density was
apparent in the heme pocket consistent with a high-occupancy
bound ligand in one monomer of the dimer and a second lower
occupancy binding site in the other. This difference in occu-
pancy is consistent with previous single-crystal structures of
DHP complexes with a range of different ligands in this space
group (see, for example, McCombs, Moreno-Chicano et al.,
2017). DCP exhibited a binding site that was virtually identical
to those previously observed for the guaiacol substrates 4-
bromoguaiacol (PDB entry 6cke), 4-nitroguaiacol (PDB entry
6ch5) and 4-methoxyguaiacol (PDB entry 6ch6) (McGuire et
al., 2018), while the 5BR complex was consistent with a
computationally hypothesized binding site (Barrios et al.,
2014), with both results together demonstrating that SFX
provides accurate substrate-binding orientations.
The details of the binding modes themselves are beyond the
scope of this manuscript and will be described in detail in a
separate publication. Strong electron-density peaks were
present for the two Cl atoms of DCP and the single Br atom of
5BR, allowing the ligand orientation to be easily confirmed,
although it is important to note that the electron density was
well defined for all atoms of the ligands. For both DHP–ligand
structures one monomer had near-full occupancy, but signifi-
cantly lower occupancy (as refined in PHENIX; Adams et al.,
2010) was observed in the second monomer of the homodimer
[Figs. 1(a) and 1(b)]. This feature allowed us to examine the
effect of ligand occupancy on ligand detectability in maps
derived from SFX data (see below).
The SFX structure of DtpAa was determined in space group
P21 to 1.88 A˚ resolution (Table 1). The overall structure of the
enzyme homodimer was highly similar to that of ferric DtpAa
crystallized in a condition that did not contain imidazole
(Ebrahim, Moreno-Chicano et al., 2019). The examination of
Fo  Fc difference maps indicated that an imidazole ligand was
coordinated via an N atom to the distal position of the heme
iron in one monomer of the DtpAa dimer with full occupancy.
The Fe—N (imidazole) bond was 2.2 A˚, while imidazole also
formed two hydrogen bonds (2.7 and 2.9 A˚) to Asp239 [Fig.
1(c)], and the heme pocket also contains several well ordered
water molecules. Comparison with the ligand-free ferric
DtpAa structure also obtained by SFX (Ebrahim, Moreno-
Chicano et al., 2019) revealed that the imidazole displaces the
distal water molecule from the heme and induces a number of
modest structural rearrangements in the heme pocket
(Supplementary Fig. S2). A second imidazole molecule is
bound to the protein away from the heme pocket, forming a
2.7 A˚ bond to Thr351 and interacting via a bridging water with
Glu283. In contrast, for monomer A no imidazole ligand was
observed in the distal heme pocket and instead a water
molecule is bound at a distance of 2.4 A˚ in a similar manner to
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Table 1
Data-collection, processing and refinement statistics for full SFX data sets for enzyme–ligand complexes.
Values in parentheses are for the outermost resolution shell.
Structure DHP–DCP DHP–5BR DtpAa–imidazole AcNiR–nitrite
Data collection and processing
Space group P212121 P212121 P21 P213
Unit-cell parameters (A˚, ) a = 60.9, b = 67.2, c = 68.7,
 =  =  = 90
a = 61.0, b = 67.3, c = 68.8,
 =  =  = 90
a = 72.5, b = 68.0, c = 73.5,
 =  = 90,  = 105.6
a = 97.6, b = 97.6, c = 97.6,
 =  =  = 90
Chips used 3 4 4 2
Images collected 76800 102800 102800 51200
Indexed images merged 32618 53662 20316 16586
Unique reflections 24749 24840 56220 24729
Resolution (A˚) 37.7–1.85 (1.90–1.85) 45.6–1.85 (1.90–1.85) 70.8–1.88 (1.93–1.88) 43.7–1.90 (1.93–1.90)
Completeness (%) 100 (100) 100 (100) 100 (100) 100 (100)
Multiplicity 579 (340) 907.7 (524.0) 101.6 (64.2) 3281.4 (2299.1)
CC1/2 0.99 (0.66) 1.00 (0.65) 0.96 (0.60) 0.99 (0.63)
Rsplit (%) 6.6 (61.9) 5.5 (66.6) 15.8 (63.9) 9.73 (58.61)
Refinement
Resolution range (A˚) 34.4–1.85 45.6–1.85 35.3–1.88 43.7–1.90
Rwork (%) 16.8 16.7 13.9 13.7
Rfree (%) 19.9 18.9 17.6 17.2
R.m.s.d., bond lengths (A˚) 0.010 0.005 0.010 0.006
R.m.s.d., bond angles () 1.23 0.96 0.87 0.90
Ramachandran most favoured (%) 98.2 98.9 98.5 98.8
PDB code 6i7f 6i6g 6i7c 6qwg
that in the ferric DtpAa structure (Ebrahim, Moreno-Chicano
et al., 2019).
The structure of AcNiR in complex with nitrite was deter-
mined to 1.90 A˚ resolution (Table 1). The type 2 Cu site, which
is the site of ligand binding, displayed clear electron density
for a bound nitrite molecule with a bidentate O-binding
geometry as previously described in multiple 100 K and room-
temperature structures obtained from single crystals (Meyder
et al., 2017; Horrell et al., 2016) [Fig. 1(d)]. The positions of the
ligand-binding sites within the protein fold for each complex
are shown in Supplementary Fig. S3.
3.3. Ligand density features as a function of the number of
diffraction patterns in a data set
As described above, all three ligands were unambiguously
identified in maps derived from the full data sets, demon-
strating that ample diffraction patterns had been included in
the merged data sets, which had good data-quality metrics
(Table 1). To test the lower limits of the number of diffraction
patterns that would allow us to identify bound ligands in high-
throughput SFX experiments, the data were partitioned into
subsets of decreasing size to produce independent merged
data sets containing progressively fewer diffraction patterns,
(Supplementary Tables S1–S4). OMIT difference maps were
generated by simulated-annealing refinement in PHENIX
(Adams et al., 2010) using the all-data structure with ligand
atoms omitted in the initial model. As expected, the merging
and refinement statistics, and consequently the resolution cut-
off, progressively deteriorated as the number of merged
patterns was reduced (Fig. 2, Supplementary Tables S1–S4,
Supplementary Fig. S4). The OMIT map quality was, as might
be reasonably expected, proportional to the number of images
in the data set. As a simple practical test to emulate a typical
crystallographic workflow, the ‘Find Ligands’ feature of Coot
(Debreczeni & Emsley, 2012; Emsley, 2017) was used to test
whether each ligand could be correctly fitted into the
simulated-annealing Fo  Fc map without bias from the
experimentalist’s prior knowledge of the correct pose.
3.4. 2,4-Dichlorophenol–DHP complex
We first examined the effect of the number of crystals
included in a data set on the resulting electron-density maps
for the complex between DHP and DCP. Very clear Fo  Fc
simulated-annealing OMIT map features for the ligand were
evident in subsets considerably smaller than the ‘full’ data sets.
For example, a subset of 5000 crystals showed merging
statistics that would still be considered acceptable by standard
assessments [Rsplit = 0.17 (0.73), CC1/2 = 0.95 (0.56) to 1.95 A˚
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Figure 1
2Fo  Fc electron-density maps, contoured at 1, showing the complexes of DHP with (a) DCP with the Cl atoms shown in green and (b) 5BR with the Br
atom shown in purple, (c) the complex of DtpAa with imidazole and (d) the complex of AcNiR with nitrite. In each case, the active site of the monomer
with the highest ligand occupancy is shown. The maps in (a)–(d) were generated using the all-image data sets.
resolution] and unsurprisingly
ligand finding was straightfor-
ward. When the data set was
reduced to containing only 1000
crystals the merging statistics
were poor [Rsplit = 0.39 (0.65),
CC1/2 = 0.72 (0.57) to 2.2 A˚ reso-
lution], and with 500 images these
metrics indicated very poor or
even meaningless data quality
[Rsplit = 0.56 (0.92), CC1/2 = 0.57
(0.42) to 2.2 A˚ resolution]. The
refinement statistics also deterio-
rated with decreasing data-set
size (Supplementary Table S1).
Remarkably, data sets com-
prising far fewer than 1000
indexed patterns displayed very
clear features in simulated-
annealing OMIT maps of the
distal pocket, covering all atoms
of the best-ordered DCP ligand
(in monomer B). Examples are
shown in Supplementary Fig. S5,
where the Fo  Fc OMIT map
allowed all atoms of the ligand to
be unambiguously modelled,
even when the merging statistics
were very poor and refinement R
factors were high (Supplemen-
tary Table S1). Because of the
poor merging statistics with
<1000 images, it was not possible
to use these metrics to assess the
resolution limit in merging for
these data; however, refinement
using the same resolution limit as
the 1000-image set still allowed
straightforward ligand placement.
For data sets produced from <400 crystals, difference map
quality rapidly deteriorated (Supplementary Fig. S5). This
deterioration of the maps appears to approximately coincide
with a loss of data completeness and redundancy in these data
sets. The lower occupancy ligand present in the second
monomer failed to be located in data-subset OMIT maps of
decreasing size more rapidly than was the case for the fully
occupied ligand (Supplementary Fig. S6). EDIAscorer
(Meyder et al., 2017) electron-density analysis is shown in Fig.
3 and Supplementary Fig. S7, showing the excellent quality of
the difference map for all ligand atoms down to very low
image numbers.
3.5. 5-Bromoindole–DHP complex
Data and map quality followed a similar pattern with
reducing crystal numbers to that described above for DCP
(Table 1, Fig. 2, Supplementary Figs. S8 and S9). In this case,
the lower occupancy of the two 5BR ligands was automatically
found in Coot with a data set from 2000 images, but this step
failed with 1000 images. For the higher occupancy 5BR ligand,
the correct pose was found down to a data set of 800 images,
while in data sets comprising 500, 600 or 700 images an
incorrect pose was found by Coot, although manual re-
orientation was straightforward based on the Fo  Fc map. A
remarkable observation is that even in a data set comprising
only 200 images (with 75.3% data completeness) the heavier
Br atom of the ligand was clearly identified, with OMIT map
peaks of 6.8 (1.83 e A˚3) in monomer B and 4.3
(1.16 e A˚3) in monomer A at its position (Supplementary
Figs. S8 and S9).
3.6. Imidazole complex of DtpAa
The imidazole ligand provided a more challenging case
owing to its smaller size in comparison to DCP and 5BR and
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Figure 2
Fo  Fc simulated-annealing OMIT maps contoured at 3 for the heme region from selected data subsets
for (a) DHP–DCP, (b) DHP–5BR, (c) DtpAa–imidazole and (d) AcNiR–nitrite, each superposed on the
refined structure from all data. For (a) and (b) the highest occupancy ligand monomer of the homodimer is
shown. Additional subsets are shown in Supplementary Figs. S5, S6 and S8–S11.
because of the lower symmetry space group (P21) of the
DtpAa crystals. For the latter reason, the merging statistics
deteriorated more rapidly than for DHP (Supplementary
Table S3). In particular, data completeness began to
deteriorate, with the 2000-image data set being essentially
complete, while this was not the case for the 1000-crystal data
set. With subsets of 5000 images or larger, Coot was able to
successfully locate both the heme-coordinated imidazole and
the second imidazole ligand located in the inter-monomer cleft
[Supplementary Fig. S3(c)]. With smaller subsets, the latter
ligand was not found, although the heme-bound imidazole was
located in data sets of as few as 800 images. In these very small
data sets the imidazole ring as positioned by Coot was some-
times rotated around its normal axis while still fitting the
symmetrical electron-density feature well, but this was readily
corrected by applying simple chemical knowledge, i.e. that N
atoms rather than C atoms should be forming the coordination
bond to the Fe atom and be oriented towards the Asp residue
in the heme pocket. Simulated-annealing OMIT maps for the
DtpAa–imidazole complex are shown in Fig. 2 and Supple-
mentary Fig. S10, with electron-density statistics in Fig. 3 and
Supplementary Fig. S7. We note that for all three ligands, even
when automated ligand finding failed, significant ligand
density was present that could allow manual identification in
cases where the binding pocket was known in advance.
3.7. AcNiR complex with nitrite
Although nitrite is the smallest ligand of interest used in this
study, AcNiR has the inherent characteristic of crystallizing in
a high-symmetry space group (P213), resulting in fewer data
being required for a complete data set owing to the high
redundancy of the data collected (Table 1). Again, very clear
Fo  Fc simulated-annealing OMIT map features for the
ligand were evident in subsets of small numbers of diffraction
patterns, despite exhibiting merging statistics that would
typically be considered rather poor (Figs. 2 and 3, Supple-
mentary Table S4 and Supplementary Fig. S11). Coot
successfully located nitrite binding at the type 2 Cu active site
in subsets of very few crystals, with 200 being the lowest
number of crystals that were needed to successfully auto-find
the nitrite ligand. Although Coot was unsuccessful at deter-
mining the ligand in the lowest crystal subset of only 100
crystals, positive electron density is still identifiable at the site
where ligand binding is expected, although this did not allow
for reasonable modelling of a ligand.
3.8. OMIT maps from simulated-annealing refinement
against ligand-free structures of the native enzymes
Although simulated-annealing refinement as described
above would reasonably be expected to remove all model bias,
as an additional validation step selected subsets were refined
against the corresponding native structures obtained by SFX
(Ebrahim, Moreno-Chicano et al., 2019; Moreno-Chicano et
al., manuscript in preparation), where the ligands were not
present. OMIT map generation followed an identical proce-
dure to that described above, with the exception of the input
coordinate file used. The resulting OMIT maps are shown in
Fig. 4 and Supplementary Figs. S12, S13 and S14) for data
subsets of differing sizes. The results of this process corre-
sponded well with the previously described OMIT maps,
suggesting that model bias was not significant in the previous
procedure for any of the complexes. Notably, for the two DHP
ligand structures, in addition to very clear OMIT map density
for the ligands themselves the map features clearly define the
movements of heme-pocket residues that are necessary to
accommodate the ligand (Fig. 4 and Supplementary Fig. S12).
This provides further evidence of the information content
within these data sets, despite the low numbers of diffraction
patterns and extremely poor statistics. Importantly, we used
AcNiR–nitrite as a very challenging case to test the limitations
of our approach as the nitrite ligand contains only three atoms
and also displaces a water molecule upon binding (Antonyuk
et al., 2005). In addition, the water density in the native
structure is disordered, with the presence of a second water
molecule a possibility. Notably, refinement of AcNiR data and
subsets versus the native AcNiR SFX structure produced clear
positive difference map features for the nitrite atoms that are
separated from the water molecule present in the native
structure (Supplementary Fig. S14). For comparison, SA OMIT
maps produced from refinement of the same subsets against
the native AcNiR SFX model with the copper-coordinated
water molecule deleted are shown in Supplementary Fig. S15.
3.9. Detection of differences between ligands from Fo  Fo
isomorphous difference maps
For the DHP case, in which two different ligands bind in a
similar binding pose to the same enzyme pocket, we tested the
ability to distinguish between these ligands using Fo  Fo
isomorphous difference maps. For the full data sets, an
Fo(DHP–5BR)  Fo(DHP–DCP) map is shown in Fig. 5.
Strong positive density (a 32 peak) is present where the Br
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Figure 3
Real-space correlation coefficient (RSCC) values from EDIAscorer
(Meyder et al., 2017) as a function of the number of images per subset.
Data are shown for the highest occupancy binding site for each complex.
A plot including values for additional binding sites is shown in
Supplementary Fig. S7.
atom of 5BR occupies a similar position to a Cl atom of DCP,
consistent with the larger number of electrons on the Br atom.
A negative feature is present over the second Cl atom of DCP,
consistent with a C atom occupying a similar position in 5BR.
Finally, a positive peak is present for the C5 atom of 5BR
where no equivalent atom is present in DCP. As the number of
crystals in a data subset decreases, the map features become
less prominent, with the C5 feature disappearing in subsets of
1000 crystals or smaller. However, the features corresponding
to the Br and Cl atoms are remarkably still evident, albeit
much weaker, in subsets comprised of as few as 200 crystals
(Fig. 5).
4. Discussion
4.1. High-throughput determination of ligand-bound SFX
structures using fixed targets
Our results indicate that high-quality SFX crystal structures
that allow unambiguous ligand identification may be achieved
using our fixed-target approach. This can be achieved using a
small quantity of enzyme sample with
high throughput and rapid switchover
between different proteins and ligands.
Typical data-collection times for
complexes were 30–60 min using all
data measured, and using these data sets
ligand modelling was clear and unam-
biguous. In comparison to previously
published data for ligand-binding
experiments (Naitow et al., 2017; Bublitz
et al., 2015), the fixed-target approach
allows the high-throughput production
of multiple intact enzyme–ligand
complex structures. In addition, the
soaking and data-collection strategy can
be easily adapted and optimized for a
synchrotron beamline using the same
sample-loading and mounting system.
Our results cover several different
ligand-binding scenarios, such as
coordinate-bond formation to a heme
iron (imidazole) or copper (nitrite) and
noncoordinate ligand binding in a
pocket (DHP ligands), with the latter
being highly relevant to the binding of
ligands to pharmacologically important
proteins such as cytochromes P450. In
each structure, binding sites are present
with different occupancies, allowing a
further test of the ability of the method
to locate high- or low-occupancy
ligands.
The limits of our ability to identify
ligand binding were tested using the
small ligands nitrite (46 Da) and
imidazole (68 Da). Both of these are
much smaller than the fragments used in
fragment-based drug design (FBDD),
where 200 Da is a typical molecular
weight (Price et al., 2017). In the case of
AcNiR, a particular challenge was that
nitrite displaces a water molecule on
binding. In AcNiR structures deter-
mined from single crystals, distin-
guishing between the electron-density
features of active-site waters and nitrite
is challenging and requires high-
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Figure 4
Difference map features produced by simulated-annealing refinement against ligand-free native
structures clearly reveal ligand binding and active-site rearrangements in the absence of the risk of
model bias. Fo  Fc OMIT maps, contoured at 3, are shown for DCP data subsets refined versus
the native DHP structure. In each case, the native DHP structure from OMIT refinement versus a
particular subset is shown in grey, while the superimposed structure of the ligand complex is shown
in blue. Positive difference map features are shown in green, with negative features in red. Note that
the flips of Phe21 and Phe60 to accommodate ligand binding, together with the ligand density itself,
are very clearly defined in the data set obtained from all data and this is maintained in the 5000-
image subset. Clear OMIT map features are apparent for Phe60 and DCP in data sets with as few as
400 images, while this was no longer the case in the 300-image subset.
resolution data (Antonyuk et al., 2005; Horrell et al., 2018).
Nonetheless, our method allowed the identification of these
ligands in subsets comprising a small fraction of the full data
sets. Our results are therefore strongly indicative that the
ligands used in FBDD will be readily detected using our
approach.
4.2. What is the minimal quantity of data required to identify
ligand-binding modes?
Analysis of simulated-annealing OMIT maps generated
from data subsets containing only a subset of merged
diffraction patterns clearly demonstrates that only a small
fraction of the total data-collection time that we used is in fact
necessary to locate ligands in the correct binding pose. For
example, for the 5BR complex of DHP a subset of just 800
indexed images (1.5% of the total number of images in the
full data set) was sufficient to correctly model the ligand using
a careful strategy to preclude the possibility of model bias. A
conservative approach of measuring several times this
minimal number would still require only a small proportion of
the 25 600 crystal positions on each chip. Our data also show
that useful information is contained in data sets obtained from
extremely small numbers of microcrystals; for example, the Br
atom of 5BR was identified in a data set of only 200 crystals
(<0.4% of the total data set).
In a lower symmetry space group (DtpAa; P21), the ability
to detect ligand binding in data sets of <2000 images was
compromised by a lack of data completeness at higher
resolution, although ligand finding was still achieved with 800
images. Notably, for the DHP structures in space group
P212121 data completeness remained good in very small data
sets; for example, for the DCP complex the 400-image data set
retained >90% completeness in the highest resolution shell.
The high completeness of data sets formed from (relatively)
small numbers of crystals parallels the success in forming
complete data sets from multiple thin wedges in virus crys-
tallography (Fry et al., 1999). The completeness of the final
data set is a function of the number of wedges collected and
the point group of the crystals used, with the prerequisite for
each approach being that the crystals must be randomly
orientated. The completeness of the data obtained from small
numbers of crystals here illustrates that this is the case for
DtpAa, DHP and AcNiR crystals on silicon chips. The band-
width of the XFEL beam allows complete data to be obtained
from fewer crystals than would be the case with a more
monochromatic beam, yet still requires many more crystals
than might be required in a wide-bandpass Laue experiment
(Meents et al., 2017). Our data strongly suggest that data
completeness is the key metric for assessing the suitability of
data sets for ligand-binding studies and that very poor values
of other typically used metrics of data quality (for example
CC1/2 and Rsplit) still allow successful ligand characterization
provided that the data are complete. For AcNiR, with cubic
symmetry, the data remained essentially complete in all of the
subset sizes analysed, with density for the nitrite ligand
remaining apparent down to <200 indexed images. We note
that substantially more diffraction patterns would be required
to obtain complete data on a monochromatic beamline.
More broadly, our data clearly show that substantial infor-
mation content is present in noisy and apparently low-quality
data sets derived from small numbers of merged diffraction
patterns with very poor merging and refinement statistics. For
example, a data set formed of 200 patterns revealed a very
clear peak for the Br atom of the 5BR ligand (outer shell
completeness 70.9% in DCP). Importantly, refinement of data
subsets against native structures unambiguously showed not
only clear density for ligands, but also any movements of the
active-site residues needed to accommodate ligand binding
(Fig. 4 and Supplementary Fig. S12). This provides conclusive
evidence that the ligand density that we describe is not owing
to model bias from prior knowledge of the binding mode.
4.3. Future potential of the ‘chip-soak’ approach for
high-throughput structure determination of protein–ligand
complexes
In this work, SFX structures were recorded from two
(AcNiR), three (DHP–DCP) or four (DHP–5BR and DtpAa–
imidazole) chips, aiming for 1–2 structures per hour. The
number of chips used for a single structure was subsequently
seen to err significantly on the side of caution, as in all cases
sufficient data for unambiguous ligand identification were
available from significantly less than half a chip. Crucially,
careful data analysis demonstrated that data sets comprising
of no more than a few hundred to a few thousand indexed
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Figure 5
Fo  Fo isomorphous difference maps comparing the 5BR and DCP
ligand complexes of DHP. Maps are Fo(5BR)  Fo(DCP) contoured at
3. With all data included, the map shows a clear positive peak near to the
position of the Br atom of 5BR (black) and one of the Cl atoms of DCP
(magenta), consistent with the greater number of electrons in bromine. A
negative peak is present at the position of the second Cl atom of DCP,
where the closest atom of 5BR is a carbon. An additional but weaker
positive peak is present close to the C5 atoms of 5BR where no atom is
present in DCP.
images are sufficient to correctly model ligands into clear
difference density features. Thus, without modification of the
approach or changes to the experimental conditions, an
approximately 4–5-fold increased throughput of multiple
protein–ligand structures per hour could easily be realized.
Rapid on-site data analysis should allow on-the-fly decision
making as to whether sufficient data have been collected for a
particular soak and if a ligand is indeed bound. A key
advantage of the fixed-target sample-delivery method is that
switching between samples of different protein–ligand soaks is
no more time-consuming than continuing with a chip of the
same sample. With typical loading rates of approximately
30%, multiple ligand soaks could be carried out on a single
redesigned chip, again drastically increasing throughput. As a
further example, for systems where approximately 1000 hits
would be sufficient, at the latter hit rate some eight ligand
complexes could be characterized on a single chip.
The sample quantity required for our approach (in the
range of 1.35–6.0 mg protein per data set) is less than required
in liquid-jet approaches, although higher than has been
reported for high-viscosity (LCP) injection systems at XFEL
(Weierstall et al., 2014) and synchrotron (Weinert et al., 2017)
beamlines. An additional factor is ligand consumption. In our
case, without optimization to minimize sample consumption,
the typical ligand quantities used were in the range 4–40 mmol.
Our system of work is applicable at other current and future
XFEL sources, such as PAL (60 Hz repetition rate), SwissFEL
(100 Hz) and LCLS (120 Hz), as well as SACLA (30 Hz).
However, XFEL sources with very high repetition rates or
complex pulse patterns (for example EuXFEL and LCLS-II)
may require a modified or different approach. We have
demonstrated that at a source with a modest repetition rate
sufficient data for multiple, unrelated, protein–ligand struc-
tures may be obtained within a couple of hours. Increasing this
level of throughput to 5–20 structures per hour at higher
repetition-rate sources, or collecting fewer images per
complex (see above) as is practical, would allow, for example,
>200 structures to be determined in a single 12 h shift, similar
to dedicated synchrotron beamlines. Fixed targets are also
well suited to time-resolved crystallography of, for example,
protein–ligand complexes using laser pump–probe methods
(Schulz et al., 2018) and it is important to note that in time-
resolved experiments significantly more data may be required
as crystals may contain a mix of states.
Another key advantage is that the chip approach allows us
to test soaking protocols at synchrotron beamlines under
identical conditions to those used at the XFEL in order to
ensure that soaking does not damage crystals and also that
ligands are bound, albeit in a radiation-damaged structure. At
such high rates of sample delivery, automation of chip loading
and robotic sample exchange will of course become increas-
ingly important. Our work demonstrates the feasibility of
high-throughput room-temperature ligand screening by SFX
using microcrystals and is highly applicable to drug-discovery
efforts, including in fragment-based drug design. Our
approach would be of particular importance in cases where
only small weakly diffracting crystals are obtained or when the
enzyme–ligand complexes are radiation-sensitive. We have
demonstrated the ability to identify ligand binding by our
high-throughput approach using ‘conventional’ approaches to
both refinement and ligand finding. Further data-analysis
improvements to the ability to identify in particular low-
occupancy ligands in FBDD could be achieved using a multi-
data-set approach, for example in PanDDa, with subtraction
of the ligand-free ground state (Pearce, Krojer, Bradley et al.,
2017) and with refinement against a composite of the ligand-
free and ligand-bound structures (Pearce, Krojer & von Delft,
2017).
In conclusion, we demonstrate (i) a method to rapidly
measure SFX data sets from protein–ligand complexes and to
rapidly switch between ligands during beamtime, (ii) that data
sets comprised of hundreds to a few thousands of diffraction
patterns can be sufficient for unambiguous ligand identifica-
tion and (iii) that even ligands smaller than those used in
fragment-based drug design may be located using our
approach. These data demonstrate the feasibility of high-
throughput structure determination of protein–ligand
complexes at XFEL sources.
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